Regend – Health Startup – China
文字稿
What if damaged lungs could heal from within? Every year, millions of people lose the ability to breathe freely.
Regend Therapeutics, a biotech startup from China, is trying to change that.
The company developed a method that uses a patient's own cells to regenerate lung tissue destroyed by chronic disease. In clinical trials, patients who could barely walk returned to daily life.
Their IP spans three continents, supporting a treatment that seeks to reimagine the future of respiratory medicine.
What if damaged lungs could heal from within? Every year, millions of people lose the ability to breathe freely.
Regend Therapeutics, a biotech startup from China, is trying to change that.
The company developed a method that uses a patient's own cells to regenerate lung tissue destroyed by chronic disease. In clinical trials, patients who could barely walk returned to daily life.
Their IP spans three continents, supporting a treatment that seeks to reimagine the future of respiratory medicine.
2026年7月10日